Browsing Tag
dostarlimab
4 posts
Could PP2A-targeted immunotherapy combinations improve outcomes in ovarian clear cell carcinoma?
Could PP2A-targeted immunotherapy reshape ovarian cancer treatment and Lixte’s valuation story? Read the executive analysis on what changes next.
April 15, 2026
Elevation Oncology strengthens cancer drug pipeline as cash reserves hit $93m
Elevation Oncology, Inc. has released its financial results for the fourth quarter and full-year 2024, outlining significant progress…
March 7, 2025
GSK secures expanded approval for Jemperli from FDA: A major advancement in endometrial cancer treatment
In a landmark decision, the US Food and Drug Administration (FDA) has extended its approval of Jemperli (dostarlimab)…
August 3, 2024
GSK completes $5.1bn acquisition of Tesaro to boost oncology pipeline
GlaxoSmithKline (GSK), the British pharmaceutical powerhouse, has successfully concluded its $5.1 billion acquisition of Tesaro, a leading oncology-focused…
February 10, 2019